A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis (AS), a valvular heart condition that can be ...

• Antibiotics seem to reduce surgical site infections in people undergoing aortic or aortoiliac surgery. • Other interventions assessed appear to make little or no difference in reducing the incidence ...

The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.

Compared with usual care, a system of electronic provider notification more often enabled patients diagnosed with severe ...

This prospective cohort‐study included adult patients undergoing aortic valve surgery or ascending aortic surgery at a single center (2007–2013). The primary outcome was aortic diameter growth; ...

Background: Following transcatheter aortic valve replacement, acute coronary obstruction is ... However, it was discovered that the patient had died suddenly one month after surgery. The suspected ...

Patients who underwent transcatheter aortic ... open heart surgery in patients who are eligible for either procedure. The study was funded by JenaValve, maker of the Trilogy valve.

Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter aortic valve replacement (TAVR) had similar rates of death or disabling ...

Data shows, versus surgery, the Evolut™ transcatheter aortic valve replacement (TAVR) system delivers a numerically lower rate of all-cause mortality or disabling stroke at five years ...

CHICAGO -- Transcatheter aortic valve replacement (TAVR) continued to hold its own against surgery for younger patients at low surgical risk, with the Evolut Low Risk trial now halfway to its goal ...

Transcatheter aortic-valve implantation (TAVI) is associated with procedure-related stroke. Cerebral embolic protection (CEP) devices may reduce embolization to the cerebral circulation and hence ...

CHICAGO, IL—Five-year follow-up for patients with severe aortic stenosis and low surgical risk affirm the benefits of TAVI with a self-expanding, supra-annular valve compared with surgery, according ...